What does Apotheek Baeyaert do?

Apotheek Baeyaert is a logistics company in Middelkerke. Private Limited, started on 31 December 1987, 1 establishment.

What is the address of Apotheek Baeyaert?

The registered office of Apotheek Baeyaert is located at Lombardsijdelaan 215, 8434 Middelkerke.

Is Apotheek Baeyaert still active?

Yes. According to the CBE (30 October 2026) Apotheek Baeyaert is active, legal situation “Normale toestand”, started on 31 December 1987.

Is Apotheek Baeyaert registered on Peppol?

Yes, Apotheek Baeyaert is registered on the Peppol network with ID 0208:0433054520.

What is the enterprise number of Apotheek Baeyaert?

The enterprise number of Apotheek Baeyaert is BE0433054520.

When was Apotheek Baeyaert founded?

Apotheek Baeyaert was founded on 31 December 1987.

Who are the directors of Apotheek Baeyaert?

According to the 2025 annual accounts, the directors of Apotheek Baeyaert are: GHYDAV BVBA.

Is Apotheek Baeyaert a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 December 1987; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Baeyaert make in 2025?

Apotheek Baeyaert posted a profit after taxes of € 137,572 in financial year 2025.

What is the revenue of Apotheek Baeyaert?

As a small company, Apotheek Baeyaert is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 272,037.

How much does an employee at Apotheek Baeyaert earn?

The average wage cost per full-time employee at Apotheek Baeyaert was € 43,900 in 2025: staff costs of € 74,657 for 1.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Baeyaert have?

According to the 2025 annual accounts, Apotheek Baeyaert has 1.7 full-time equivalents (FTE).

Does Apotheek Baeyaert have a website?

Yes, Apotheek Baeyaert has a website at apotheekbaeyaert.be.

Apotheek Baeyaert (Private Limited) - Middelkerke

Dossier Apotheek Baeyaert, printed on 30 October 2026 from databakkes.be/en/0433054520/apotheek-baeyaert. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Baeyaert from Middelkerke, company number BE0433054520, closed financial year 2025 with a result of € 137,572 after tax. For that financial year Apotheek Baeyaert recorded a gross margin of € 272,037 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 112,447 to € 137,572. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.

What it is worth Growing

€ 1.1 million

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 137,572

▲ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 975,125

▲ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.1 million.

People and assets in 2025

Full-time equivalents

1.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 74,657

▲ 5% vs 2024

€ 43,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,489

▼ 45% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 260,869

▲ 119% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,352

▼ 48% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 260,133 Gross margin 2022: € 260,133 First fiscal year in the series	€ 207,429 Gross margin 2023: € 207,429 ▼ 20% vs 2022 (€ 260,133) Unfavourable step	€ 249,617 Gross margin 2024: € 249,617 ▲ 20% vs 2023 (€ 207,429) Favourable step	€ 272,037 Gross margin 2025: € 272,037 ▲ 9% vs 2024 (€ 249,617) Favourable step	▲ 9%
Profit after taxes	€ 131,330 Profit after taxes 2022: € 131,330 First fiscal year in the series	€ 63,311 Profit after taxes 2023: € 63,311 ▼ 52% vs 2022 (€ 131,330) Unfavourable step	€ 112,447 Profit after taxes 2024: € 112,447 ▲ 78% vs 2023 (€ 63,311) Favourable step	€ 137,572 Profit after taxes 2025: € 137,572 ▲ 22% vs 2024 (€ 112,447) Favourable step	▲ 22%
Equity	€ 815,511 Equity 2022: € 815,511 First fiscal year in the series	€ 878,822 Equity 2023: € 878,822 ▲ 8% vs 2022 (€ 815,511) Favourable step	€ 991,268 Equity 2024: € 991,268 ▲ 13% vs 2023 (€ 878,822) Favourable step	€ 1,128,841 Equity 2025: € 1,128,841 ▲ 14% vs 2024 (€ 991,268) Favourable step	▲ 14%
Total debts	€ 710,168 Total debts 2022: € 710,168 First fiscal year in the series	€ 443,957 Total debts 2023: € 443,957 ▼ 37% vs 2022 (€ 710,168) Favourable step	€ 213,701 Total debts 2024: € 213,701 ▼ 52% vs 2023 (€ 443,957) Favourable step	€ 344,305 Total debts 2025: € 344,305 ▲ 61% vs 2024 (€ 213,701) Unfavourable step	▲ 61%
Cash	€ 1,085,069 Cash 2022: € 1,085,069 First fiscal year in the series	€ 819,628 Cash 2023: € 819,628 ▼ 24% vs 2022 (€ 1,085,069) Unfavourable step	€ 723,990 Cash 2024: € 723,990 ▼ 12% vs 2023 (€ 819,628) Unfavourable step	€ 975,125 Cash 2025: € 975,125 ▲ 35% vs 2024 (€ 723,990) Favourable step	▲ 35%
Land & buildings	€ 17,268 Land & buildings 2022: € 17,268 First fiscal year in the series	€ 22,979 Land & buildings 2023: € 22,979 ▲ 33% vs 2022 (€ 17,268) Unchanged	€ 20,981 Land & buildings 2024: € 20,981 ▼ 9% vs 2023 (€ 22,979) Unchanged	€ 18,984 Land & buildings 2025: € 18,984 ▼ 10% vs 2024 (€ 20,981) Unchanged	▼ 10%
Retained profit	€ 796,911 Retained profit 2022: € 796,911 First fiscal year in the series	€ 860,222 Retained profit 2023: € 860,222 ▲ 8% vs 2022 (€ 796,911) Favourable step	€ 972,668 Retained profit 2024: € 972,668 ▲ 13% vs 2023 (€ 860,222) Favourable step	€ 1,110,241 Retained profit 2025: € 1,110,241 ▲ 14% vs 2024 (€ 972,668) Favourable step	▲ 14%
Bank debt	€ 2,000 Bank debt 2022: € 2,000 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 2,000) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,525,678 Balance sheet total 2022: € 1,525,678 First fiscal year in the series	€ 1,322,779 Balance sheet total 2023: € 1,322,779 ▼ 13% vs 2022 (€ 1,525,678) Unchanged	€ 1,204,970 Balance sheet total 2024: € 1,204,970 ▼ 9% vs 2023 (€ 1,322,779) Unchanged	€ 1,473,146 Balance sheet total 2025: € 1,473,146 ▲ 22% vs 2024 (€ 1,204,970) Unchanged	▲ 22%
Employees (FTE)	1.3 Employees (FTE) 2022: 1.3 First fiscal year in the series	1.9 Employees (FTE) 2023: 1.9 ▲ 0.6 vs 2022 (1.3) Unchanged	1.7 Employees (FTE) 2024: 1.7 ▼ 0.2 vs 2023 (1.9) Unchanged	1.7 Employees (FTE) 2025: 1.7 Unchanged (1.7) Unchanged

Key figures of Apotheek Baeyaert, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Baeyaert?

What happened at Apotheek Baeyaert in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 3, 2026 New annual accounts for financial year 2025: profit of € 137,572 (▲ 22% vs 2024). Source: NBB ↗
Jun 25, 2002 New establishment in Middelkerke. KBO
Dec 31, 1987 Start of the company according to the CBE. KBO

In short

From € 131,330 profit in 2022 to € 137,572 profit in 2025.

Paid € 150,865 in corporate taxes since 2022.

Best year ever: 2025, with € 137,572 profit.

On average € 160,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

GHYDAV 100%

The stake of GHYDAV comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Baeyaert

Behind Apotheek Baeyaert is GHYDAV BVBA. The shares are held by GHYDAV (100%).

Directors

According to the 2025 annual accounts

GHYDAV BVBA

Director

Shareholders

GHYDAV

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lombardsijdelaan 215

8434 Middelkerke

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

GHYDAV same network

€ 241,536 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekbaeyaert.be

Technologies

ApacheBootstrapCookie ConsentGoogle AnalyticsGoogle FontsVue.jsjQueryjsDelivrreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

COMBELL-AS, BE

Website info

HTTPS Ja

Languages NL

Features

Blog Contact page

Security

✓ HTTPS

✗ SPF

✗ DMARC

Details

Company number

0433.054.520

VAT number

BE 0433.054.520

Registered office

Lombardsijdelaan 215, 8434 Middelkerke

Names & denominations

Apotheek Baeyaert

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

31 December 1987

Peppol

Active · Active since 28 Aug 2023

Contact

apotheekbaeyaert.be

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Baeyaert

Financials

What happened to Apotheek Baeyaert?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions